Next Science Appoints Harry Thomas Hall, IV as CEO

Next Science Limited (ASX: NXS), a medical technology company specializing in reducing biofilm-based infections in human health, has announced the appointment of Harry Thomas Hall, IV (commonly known as "I.V.") as its new Managing Director and Chief Executive Officer (CEO). I.V. brings 28 years of experience in the global medical device industry, with expertise in product development, global strategic marketing, commercial operations, and sales leadership.

Previously, I.V. held senior roles at DePuy Synthes, a subsidiary of Johnson and Johnson, including Global Vice President - MedTech R&D and Worldwide President - Trauma, Extremities, Craniomaxillofacial & Animal Health. He was also a member of the Global Leadership Team and R&D Leadership Team for DePuy Synthes and oversaw the launch of the company's first surgical robot. In his role as Worldwide President of Trauma, Extremities, Craniomaxillofacial and Animal Health, I.V. was responsible for managing a global portfolio and execution strategy worth US$3.2 billion.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com